BNP Paribas Financial Markets Has $4.27 Million Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

BNP Paribas Financial Markets increased its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 26.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,067 shares of the company's stock after purchasing an additional 6,671 shares during the period. BNP Paribas Financial Markets owned approximately 0.18% of Addus HomeCare worth $4,266,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. raised its position in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock valued at $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC acquired a new position in Addus HomeCare in the 2nd quarter valued at $31,000. Farther Finance Advisors LLC raised its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the period. Innealta Capital LLC acquired a new position in Addus HomeCare during the 2nd quarter worth $44,000. Finally, Sandia Investment Management LP acquired a new position in Addus HomeCare during the 2nd quarter worth $58,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the firm's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of the company's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Stock Down 2.7 %

ADUS traded down $3.33 during trading on Thursday, reaching $120.27. 111,741 shares of the company's stock were exchanged, compared to its average volume of 130,749. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The company has a market capitalization of $2.18 billion, a P/E ratio of 27.52, a PEG ratio of 2.14 and a beta of 1.01. The business has a 50 day moving average price of $126.46 and a 200 day moving average price of $123.90.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm's revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 earnings per share. As a group, research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price target on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Tuesday. Finally, Macquarie reiterated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.